ANDA 74454, held by Cosette Pharmaceuticals. Albuterol Sulfate.
As of Nov 21, 2026, ANDA 74454 (Albuterol Sulfate), held by Cosette Pharmaceuticals, was first approved by FDA on Sep 25, 1995, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 25, 1995 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Albuterol SulfateEQ 2MG BASE/5ML · syrup;oral | Albuterol Sulfate | Discontinued |
| Jun 10, 2015 | Supplement 30Labeling | Approved | None posted |
| Dec 3, 2002 | Supplement 11Manufacturing | Approved | None posted |
| May 18, 2001 | Supplement 10Manufacturing | Approved | None posted |
| Oct 16, 2000 | Supplement 8Manufacturing | Approved | None posted |
| Jul 13, 1999 | Supplement 6Labeling | Approved | None posted |
| Jul 7, 1999 | Supplement 3Manufacturing | Approved | None posted |
| Jul 7, 1999 | Supplement 4Labeling | Approved | None posted |
| Jul 7, 1999 | Supplement 5Manufacturing | Approved | None posted |
| Jan 12, 1999 | Supplement 2Labeling | Approved | None posted |
| Sep 25, 1995 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters